Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
researcher position in mass spectrometry-based metabolomics for biomarker discovery Department of Chemistry for Life Sciences conducts research and education in analytical chemistry, biochemistry and organic
-
from basic applications, such as quantitative measurement of stable-isotope labeled peptides to clinical translational studies in diagnostic and therapeutic biomarkers for Alzheimer’s disease. We have an
-
The +Pec Proteomics Research Group (+PPRG), led by Dr. Xavier Gallart-Palau and Dr. Aida Serra at the Biomedical Research Institute of Lleida (IRBLleida, Spain) and University of Lleida [https
-
Post-doctoral Fellow in the Department of Orthopaedics and Traumatology, School of Clinical Medicine
biomarkers and therapeutic targets. Prepare high-quality manuscripts for publication in international peer-reviewed journals. Assist in the supervision of postgraduate students and junior research staff
-
The University of North Carolina at Greensboro | Greensboro, North Carolina | United States | 7 days ago
metabolomic studies of human diseases, using state-of-the-art instrumentation and tools for biomarker discovery/validation and a better understanding of the pathogenic mechanism of human disease. The position
-
prodromal cohorts and link them to clinical readouts and α-synuclein reactivity. Use cutting-edge single-cell and immune-profiling approaches, linked to clinical phenotyping, to discover early biomarkers and
-
. The outcomes of this PhD include: (i) the development of an original fracture-testing methodology for pelvic soft tissues, (ii) the identification of biomechanical biomarkers of menopausal tissue fragility, and
-
disease. The molecular mechanisms driving the individual endotypes of severe asthma have not been fully characterized, and in vitro model to develop endotype-specific therapeutic interventions or biomarkers
-
interdisciplinary Postdoctoral Researcher to join the project “Plasma p-tau217 biomarker enriched analyses in a multidomain AD prevention trial.” This project investigates how plasma p-tau217 -one of the most
-
) acquire a pathological fibrotic and immunosuppressive state that promotes tumor progression. Using a set of preclinical models, the project aims to identify novel therapeutic targets and biomarkers based